BOSSRA
TMO icon

B.O.S.S. Retirement Advisors’s Thermo Fisher Scientific TMO Stock Holding History

B.O.S.S. Retirement Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
456
-95
-17% -$45.6K 0.06% 140
2026
Q1 		$271K Sell
551
-8
-1% -$4.34K 0.08% 137
2025
Q4 		$324K Sell
559
-36
-6% -$20.4K 0.1% 125
2025
Q3 		$289K Buy
595
+5
+0.8% +$2.33K 0.07% 157
2025
Q2 		$239K Buy
590
+54
+10% +$22.6K 0.06% 169
2025
Q1 		$267K Sell
536
-99
-16% -$53.6K 0.08% 148
2024
Q4 		$330K Sell
635
-9,585
-94% -$5.27M 0.09% 136
2024
Q3 		$6.32M Buy
10,220
+1,594
+18% +$944K 1.27% 18
2024
Q2 		$4.77M Buy
8,626
+2,879
+50% +$1.65M 1.22% 18
2024
Q1 		$3.05M Sell
5,747
-670
-10% -$376K 1.17% 22
2023
Q4 		$3.41M Buy
6,417
+992
+18% +$480K 0.66% 35
2023
Q3 		$2.75M Buy
5,425
+414
+8% +$221K 0.59% 42
2023
Q2 		$2.61M Buy
5,011
+1,275
+34% +$688K 0.56% 41
2023
Q1 		$2.15M Sell
3,736
-36
-1% -$20.3K 0.51% 61
2022
Q4 		$2.08M Buy
+3,772
New +$2M 0.53% 65

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

B.O.S.S. Retirement Advisors's TMO Position: Q2 2026 in Review

B.O.S.S. Retirement Advisors reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $45.6K and leaving 456 shares worth $229K. The position accounts for 0.06% of the portfolio, ranked #140.

B.O.S.S. Retirement Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.32M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • B.O.S.S. Retirement Advisors held 456 shares of Thermo Fisher Scientific worth $229K as of Q2 2026.
  • B.O.S.S. Retirement Advisors sold 95 Thermo Fisher Scientific shares in Q2 2026, an estimated $45.6K.
  • Thermo Fisher Scientific made up 0.06% of B.O.S.S. Retirement Advisors's portfolio in Q2 2026, its #140 holding.
  • B.O.S.S. Retirement Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • B.O.S.S. Retirement Advisors's Thermo Fisher Scientific position peaked at $6.32M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.